Form D · Biotechnology
Basecamp Bio Inc.
South San Francisco, CA · CIK 0001889056
Offering snapshot reported Oct 21, 2021 · SEC filing
- Reported sold
- $9M Offering amount: $14M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 22, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 21, 2021 | Initial | $9,000,000 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-417877
Source: Form D, filed Oct 21, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Weimin Liu | Director |
| Petpiboon Prasit | Director |
| Raymond Stevens | Director |
| Robert Weisskoff | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
611 Gateway Blvd Suite 223
South San Francisco, CA, 94080
South San Francisco, CA, 94080